山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (6): 57-63.doi: 10.6040/j.issn.1671-7554.0.2021.0304
牛群,石婧婧,符江
NIU Qun, SHI Jingjing, FU Jiang
摘要: 目的 探讨WNT5A基因过表达与颗粒细胞胰岛素抵抗发生的相关性。 方法 选取3周龄(n=15只)和6周龄(n=16只)雌性昆明小鼠,采用免疫组织化学和实时荧光定量聚合酶链反应(qRT-PCR)检测Wnt5a在小鼠卵巢颗粒细胞中的表达特征;通过Forskolin+pma模拟促黄体生成素( LH)峰处理人的卵巢颗粒细胞系24 h,检测LH峰作用后颗粒细胞的WNT5A表达对胰岛素反应性的影响;利用p-EGFP-N1-WNT5A转染KGN细胞系,检测过表达WNT5A与颗粒细胞胰岛素抵抗发生的相关性。 结果 与动情前期相比,Wnt5a在6周小鼠动情期(n=3,F=8.874,P=0.017)和动情后期(n=3,F=8.874,P=0.001)的卵巢中mRNA转录水平升高,在成熟卵泡颗粒细胞中蛋白表达水平升高。与未促排卵处理相比,促排卵处理可促进卵巢颗粒细胞Wnt5a mRNA转录水平升高(n=3,F=12.093,P=0.003),抑制KGN细胞的胰岛素反应性,而WNT5A则改善其胰岛素反应性。与转染质粒空载处理相比,过表达WNT5A导致胰岛素通路反应性降低,乳酸代谢降低(n=3,F=15.281,P<0.001)。 结论 卵巢排卵过程中WNT5A的表达水平升高,有利于增强颗粒细胞对胰岛素的反应性;而类似在多囊卵巢综合征(PCOS)患者中WNT5A表达异常升高时,可能会引起PCOS相关的胰岛素抵抗的发生。
中图分类号:
[1] Nardo LG, Patchava S, Laing I. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications [J]. Panminerva Med, 2008, 50(4): 267-278. [2] 孙迪, 李蓉. 慢性非特异性炎症在多囊卵巢综合征发病作用中的研究进展[J]. 中国妇产科临床杂志, 2018, 19(2): 180-181. SUN Di, LI Rong. Research progress of chronic nonspecific inflammation in the pathogenesis of polycystic ovary syndrome [J]. Chinese Journal of Clinical Obstetrics and Gynecology, 2018, 19(2): 180-181. [3] Waldstreicher J, Santoro NF, Hall JE, et al. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization[J]. J Clin Endocrinol Metab, 1988, 66(1):165-172. [4] Tarlatzis BC, Grimbizis G, Pournaropoulos F, et al. The prognostic value of basal luteinizing hormone: follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques [J]. Hum Reprod, 1995, 10(10): 2545-2549. [5] Zhao Y, Zhang C, Huang Y, et al. Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-kappaB signaling in the granulosa cells of PCOS patients [J]. J Clin Endocrinol Metab, 2015, 100(1): 201-211. [6] Ouchi N, Higuchi A, Ohashi K, et al. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity [J]. Science, 2010, 329(5990): 454-457. [7] Richards JS. From Follicular Development and ovulation to ovarian cancers: an unexpected Journey [J]. Vitam Horm 2018, 107: 453-472. doi: 10.1016/bs.vh.2018.01.019. [8] Richards JS, Pangas SA. The ovary: basic biology and clinical implications [J]. J Clin Invest, 2010, 120(4): 963-972. [9] Hernandez Gifford JA. The role of WNT signaling in adult ovarian folliculogenesis [J]. Reproduction, 2015, 150(4): 137-148. [10] Huelsken J, Behrens J. The Wnt signaling pathway [J]. J Cell Sci, 2002,115(21): 3977-3978. [11] Wiese KE, Nusse R, van Amerongen R. Wnt signalling: conquering complexity [J]. Development, 2018, 145(12): 1-9. [12] Bothun AM, Woods DC. Dynamics of WNT signaling components in the human ovary from development to adulthood [J]. Histochem Cell Biol, 2019,151(2): 115-123. [13] Boyer A, Goff AK, Boerboom D. WNT signaling in ovarian follicle biology and tumorigenesis [J]. Trends Endocrinol Metab, 2010, 21(1): 25-32. [14] Abedini A, Zamberlam G, Lapointe E, et al. WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling [J]. Faseb J, 2016, 30(4): 1534-1547. [15] Prgomet Z, Axelsson L, Lindberg P, et al. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression [J]. J Oral Pathol Med, 2015, 44(10): 776-784. [16] Qiao X, Niu X, Shi J, et al. Wnt5a regulates Ameloblastoma Cell Migration by modulating Mitochondrial and Cytoskeletal Dynamics [J]. J Cancer, 2020, 11(18): 5490-5502. [17] Simonetti M, Kuner R. Spinal wnt5a plays a key role in spinal dendritic spine remodeling in neuropathic and inflammatory pain models and in the proalgesic effects of peripheral wnt3a [J]. J Neurosci, 2020, 40(35): 6664-6677. [18] Lopez-Bergami P, Barbero G. The emerging role of Wnt5a in the promotion of a pro-inflammatory and immunosuppressive tumor microenvironment [J]. Cancer Metastasis Rev, 2020, 39(3): 933-952. [19] 侯明粟, 徐军全. 氧化低密度脂蛋白通过Wnt5a/PKCδ信号通路诱导大鼠肝星状细胞自噬[J]. 中国细胞生物学学报, 2021, 43(3): 519-530. HOU Mingsu, XU Junquan. Oxidation low lipoprotein induces autophagy in rat hepatic stellate cells through the Wnt5a/PKCδ signaling pathway [J]. Chinese Journal of Cell Biology, 2021, 43(3): 519-530. [20] Abedini A, Zamberlam G, Boerboom D, et al. Non-canonical WNT5A is a potential regulator of granulosa cell function in cattle [J]. Mol Cell Endocrinol, 2015, 403: 39-45. doi: 10.1016/j.mce.2015.01.017. [21] Catalan V, Gomez-Ambrosi J, Rodriguez A, et al. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation [J]. J Clin Endocrinol Metab, 2014, 99(8): 1407-1417. [22] Fuster JJ, Zuriaga MA, Ngo DT, et al. Noncanonical Wnt signaling promotes obesity-induced adipose tissue inflammation and metabolic dysfunction independent of adipose tissue expansion [J]. Diabetes, 2015, 64(4): 1235-1248. [23] DeFronzo RA, Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM[J]. Diabetes, 1988, 37(6): 667-687. [24] DeFronzo RA. Pathogenesis of type 2 diabetes mellitus [J]. Med Clin North Am, 2004, 88(4): 787-835. [25] Defronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus [J]. Diabetes, 2009, 58(4): 773-795. [26] Watada H, Tamura Y. Impaired insulin clearance as a cause rather than a consequence of insulin resistance [J]. J Diabetes Investig, 2017, 8(6): 723-725. [27] Hansen SL, Svendsen PF, Jeppesen JF, et al. Molecular mechanisms in skeletal muscle underlying insulin resistance in women who are lean with polycystic ovary syndrome [J]. J Clin Endocrinol Metab, 2019, 104(5): 1841-1854. [28] Honka MJ, Latva-Rasku A, Bucci M, et al. Insulin-stimulated glucose uptake in skeletal muscle, adipose tissue and liver: a positron emission tomography study [J]. Eur J Endocrinol, 2018, 178(5): 523-531. |
[1] | 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-. |
[2] | 宋甜,付琳琳,王秋敏,杨晓,王莹,边月红,石玉华. 脂肪酸转运蛋白1在多囊卵巢综合征患者颗粒细胞中的表达[J]. 山东大学学报 (医学版), 2022, 60(2): 22-26. |
[3] | 哈灵侠,殷婷,吴阳阳,黎维霞,杜玉冬. 多囊卵巢综合征患者中胰岛素抵抗与子宫内膜局部炎症因子及葡萄糖转运蛋白-4表达的相关性[J]. 山东大学学报 (医学版), 2021, 59(11): 41-47. |
[4] | 丁祥云,于清梅,张文芳,庄园,郝晶. 胰岛素样生长因子II在84例多囊卵巢综合征患者颗粒细胞中的表达和促排卵结局的相关性[J]. 山东大学学报 (医学版), 2020, 1(7): 60-66. |
[5] | 徐红照,郝宗山, 沈德嫱,李朝苹,陈立勇. 核糖体蛋白S6激酶2沉默在乙醇诱导的心肌胰岛素抵抗中的作用[J]. 山东大学学报 (医学版), 2020, 58(4): 84-89. |
[6] | 王莹,张雅菲,文勇. 过表达YAP基因通过PI3K/AKT/mTOR信号通路促进舌鳞癌增殖[J]. 山东大学学报 (医学版), 2020, 58(2): 21-28. |
[7] | 吴成威,孙博实,周军德,蒋天明,迟强. 术前口服多糖溶液对结直肠癌患者术后胰岛素抵抗的关联性研究[J]. 山东大学学报 (医学版), 2019, 57(9): 48-53. |
[8] | 贺婷婷,刘红,舒凯云,宋晓翠,石玉华. 多囊卵巢综合征患者颗粒细胞中microRNA-141的表达与意义[J]. 山东大学学报 (医学版), 2019, 57(5): 116-120. |
[9] | 贺婷婷,刘昕,刘洪彬,赵世刚,张秀清,刘庆庆,游力,石玉华. 多囊卵巢综合征患者颗粒细胞叉头框蛋白O1 mRNA的表达与意义[J]. 山东大学学报 (医学版), 2019, 57(2): 75-79. |
[10] | 舒心,王群,黄涛,赵世刚,石玉华,刘洪彬. 多囊卵巢综合征高雄激素血症患者颗粒细胞FBP1基因的表达及影响[J]. 山东大学学报 (医学版), 2018, 56(4): 58-63. |
[11] | 王敏,王春花,刘鸿丽,何志良,崔薇薇,王磊,刘杰军. 男性儿童瘦素抵抗对成年后健康状况的影响[J]. 山东大学学报 (医学版), 2018, 56(10): 114-118. |
[12] | 王玉红,张丽红,王林省,陈月芹,王彦辉,王皆欢,李传福. 消化道颗粒细胞瘤的影像学表现[J]. 山东大学学报(医学版), 2017, 55(8): 66-70. |
[13] | 李健,徐冰,闫新峰,徐万菊,常晓天. 筛选TXNDC5与胰岛素相关信号通路关键基因的探讨[J]. 山东大学学报(医学版), 2017, 55(3): 88-93. |
[14] | 李洪志,申永超,刘洁婷,赵孝金,初彦辉,袁晓环. 11β-HSD1抑制剂改善db/db小鼠胰岛素敏感性的实验研究[J]. 山东大学学报(医学版), 2017, 55(10): 59-64. |
[15] | 李婧博,刘洪彬,贾月月,王泽,孙梅,石玉华. microRNA-183在PCOS胰岛素抵抗中的表达及其临床意义[J]. 山东大学学报(医学版), 2017, 55(1): 69-74. |
|